MAPK1 and acute myeloid leukemia: Thus, the enlarged PML-NBs can be a hallmark of conflicting cell cycle signals, driven by the activation of mitogenic ERK signaling under conditions of cell cycle arrest, contributing to the observed anti-AML effects.